Corteva (NYSE:CTVA) Releases Quarterly Earnings Results

Corteva (NYSE:CTVA) issued its quarterly earnings results on Wednesday. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.81), Zacks reports. Corteva had a net margin of 5.66% and a return on equity of 10.18%. Corteva updated its FY 2026 guidance to 0.760-0.800 EPS.

Corteva Trading Up 0.2%

Shares of NYSE:CTVA traded up $0.03 on Wednesday, reaching $12.20. 13,196,040 shares of the company traded hands, compared to its average volume of 8,034,034. The business’s 50-day simple moving average is $41.93 and its 200 day simple moving average is $70.50. Corteva has a 52 week low of $11.24 and a 52 week high of $90.97. The stock has a market capitalization of $8.14 billion, a P/E ratio of 8.08, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, December 1st. This is a negative change from Corteva’s previous quarterly dividend of $0.18. This represents a $0.20 annualized dividend and a yield of 1.6%. Corteva’s dividend payout ratio (DPR) is currently 13.25%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on CTVA shares. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $20.00 target price on shares of Corteva in a research note on Thursday, October 8th. Royal Bank Of Canada reiterated an “outperform” rating and set a $17.00 target price on shares of Corteva in a research report on Wednesday, October 7th. Zacks Research cut shares of Corteva from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 6th. KeyCorp raised shares of Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 price target on the stock in a report on Wednesday, October 7th. Finally, Oppenheimer set a $17.00 price objective on shares of Corteva in a research report on Monday, October 5th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $60.59.

Corteva Company Profile

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.